financetom
Business
financetom
/
Business
/
Kimberly Clark Insider Sold Shares Worth $2,006,117, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kimberly Clark Insider Sold Shares Worth $2,006,117, According to a Recent SEC Filing
Aug 4, 2025 11:07 AM

01:53 PM EDT, 08/04/2025 (MT Newswires) -- Zackery A Hicks, Chief Digital & Technology Officer, on August 04, 2025, sold 15,038 shares in Kimberly Clark ( KMB ) for $2,006,117. Following the Form 4 filing with the SEC, Hicks has control over a total of 14,321 common shares of the company, with 14,321 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/55785/000122520825006966/xslF345X05/doc4.xml

Price: 132.54, Change: +1.90, Percent Change: +1.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Core Scientific's board asks shareholders to vote for CoreWeave deal
Core Scientific's board asks shareholders to vote for CoreWeave deal
Oct 15, 2025
Oct 15 (Reuters) - Core Scientific's ( CORZ ) board urged its shareholders on Wednesday to vote for the company's proposed sale to CoreWeave ( CRWV ). CoreWeave ( CRWV ) announced its intention to buy Core Scientific ( CORZ ) in an all-stock deal valued at about $9 billion in July. The proposed deal faces opposition from the crypto...
Viatris Closes Acquisition of Aculys Pharma
Viatris Closes Acquisition of Aculys Pharma
Oct 15, 2025
05:13 PM EDT, 10/15/2025 (MT Newswires) -- Viatris ( VTRS ) said late Wednesday it closed the acquisition of Aculys Pharma, including rights to develop and commercialize central nervous system therapy assets pitolisant and spydia, in Japan and some markets in the Asia-Pacific region. Under the agreement, Viatris ( VTRS ) made an upfront payment to Aculys Pharma, with provision...
Spyre Therapeutics Closes $316.2 Million Public Offering
Spyre Therapeutics Closes $316.2 Million Public Offering
Oct 15, 2025
05:13 PM EDT, 10/15/2025 (MT Newswires) -- Spyre Therapeutics ( SYRE ) said late Wednesday it closed its public offering of about 17.1 million common shares, including the full exercise of underwriters' overallotment option to buy 2.2 million shares, for gross proceeds of roughly $316.2 million. The shares were sold at $18.50 each, the company said. ...
Bitfarms Plans $300 Million Convertible Notes Offering
Bitfarms Plans $300 Million Convertible Notes Offering
Oct 15, 2025
05:12 PM EDT, 10/15/2025 (MT Newswires) -- Bitfarms ( BITF ) said late Wednesday it is planning to offer $300 million of convertible senior notes due 2031. The company said it expects to grant initial purchasers an option to buy up to an additional $60 million of the notes. It plans to use the net proceeds for general corporate purposes....
Copyright 2023-2026 - www.financetom.com All Rights Reserved